enoxacin has been researched along with Spinal Diseases in 1 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Spinal Diseases: Diseases involving the SPINE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, RR | 1 |
Newman, E | 1 |
1 other study available for enoxacin and Spinal Diseases
Article | Year |
---|---|
Oral enoxacin used to cure spinal osteomyelitis due to aminoglycoside-resistant Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Enoxacin; Humans; Male; Middle Aged; Naphthyridines; Osteomyelitis; Pseudomon | 1985 |